SCA
MR

Southpoint Capital Advisors’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Southpoint Capital Advisors’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-300,000
Closed -$10.9M – 53
2013
Q4 		$10.9M Buy
+300,000
New +$11.7M 0.59% 33

Other funds holding MR

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
GAM
Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
TGA
Trilogy Global Advisors Winter Park, Florida $712K AUM 8.54% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Southpoint Capital Advisors's MR Position: Q1 2014 in Review

Southpoint Capital Advisors sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2014, closing a stake of 300,000 shares — an estimated $10.9M sold.

Southpoint Capital Advisors first reported a position in MR in Q4 2013 and held it in 1 quarter. The position peaked at $10.9M in Q4 2013. 153 funds tracked by Wall St. Rank hold MR as of Q1 2014.

  • Southpoint Capital Advisors reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2014 after selling out during the quarter.
  • Southpoint Capital Advisors sold 300,000 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2014, an estimated $10.9M.
  • Southpoint Capital Advisors first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q4 2013 and held it in 1 quarter.
  • Southpoint Capital Advisors's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $10.9M in Q4 2013.
  • 153 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2014.

Based on Southpoint Capital Advisors's 13F filing for Q1 2014, filed 15 May 2014.